Sumitomo Chemical India Third Quarter 2025 Earnings: Misses Expectations
Sumitomo Chemical India (NSE:SUMICHEM) Third Quarter 2025 Results
Key Financial Results
- Revenue: ₹6.73b (up 24% from 3Q 2024).
- Net income: ₹869.5m (up 59% from 3Q 2024).
- Profit margin: 13% (up from 10% in 3Q 2024). The increase in margin was driven by higher revenue.
- EPS: ₹1.74 (up from ₹1.10 in 3Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Sumitomo Chemical India Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 8.4%.
Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India.
Performance of the Indian Chemicals industry.
The company's shares are up 1.3% from a week ago.
Balance Sheet Analysis
While earnings are important, another area to consider is the balance sheet. See our latest analysis on Sumitomo Chemical India's balance sheet health.
If you're looking to trade Sumitomo Chemical India, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentNew: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:SUMICHEM
Sumitomo Chemical India
Engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally.
Flawless balance sheet with solid track record.
